BioLink x Dr. Sharon Shacham

​BioLink is honored to host Dr. Sharon Shacham, Founder, Former President, and CSO of the American biotechnology company Karyopharm Therapeutics.

​Dr. Shacham is arriving in person from the United States to share the scientific and strategic journey behind Selinexor – a first-in-class, FDA-approved treatment for multiple myeloma and B-cell lymphoma.

​With a Ph.D. in computational biophysics and an MBA from Tel Aviv University, Dr. Shacham has led Karyopharm from early-stage research to a successful NASDAQ IPO and international clinical impact.

​This is a rare opportunity to hear firsthand from a global leader in Biotech innovation!

​The event will be held in Hebrew

Agenda:
18:00–18:15 – Gathering and refreshments
18:15–18:20 – Club introduction
18:20–19:20 – Lecture by Dr. Sharon Shacham
19:20–19:40 – Audience Q&A